ADMS - Adamas Pharma beats by $0.12 beats on revenue November, 01 2018 04:04 PM Adamas Pharmaceuticals Inc. Adamas Pharma (NASDAQ:ADMS): Q3 GAAP EPS of -$1.22 beats by $0.12. Revenue of $10.6M beats by $0.46M. Press Release More news on: Adamas Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news,